Literature DB >> 1487844

Differences between two questionnaires for assessment of typus melancholicus, Zerssen's F-list and Kasahara's scale: the validity and relationship to DSM-III-R personality disorders.

T Sato1, K Sakado, S Sato.   

Abstract

We examined the validity in various settings of two questionnaires for assessment of Typus melancholicus, F-list and Kasahara's scale, and characterological differences between the questionnaires, based on data in 69 patients with unipolar depression and 386 normal controls without a history of depression. The questionnaires were performed on both groups. In addition, a diagnosis of DSM-III-R personality disorders was done for the patient group. Our results demonstrated that Kasahara's scale has much more stable validity in various settings for distinction between personalities of the two groups, and that high scorers in Kasahara's scale have more obsessionality and less personality instability than those in F-list. Such differences between the questionnaires suggested that a direct international comparison of premorbid personality of unipolar depressive patients is needed.

Entities:  

Mesh:

Year:  1992        PMID: 1487844     DOI: 10.1111/j.1440-1819.1992.tb00534.x

Source DB:  PubMed          Journal:  Jpn J Psychiatry Neurol        ISSN: 0912-2036


  2 in total

1.  Dimensions of the Typus melancholicus personality type.

Authors:  Klaus-Thomas Kronmüller; Matthias Backenstrass; Karen Kocherscheidt; Aoife Hunt; Peter Fiedler; Christoph Mundt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-05-20       Impact factor: 5.270

2.  Development and validation of the 22-item Tarumi's Modern-Type Depression Trait Scale: Avoidance of Social Roles, Complaint, and Low Self-Esteem (TACS-22).

Authors:  Takahiro A Kato; Ryoko Katsuki; Hiroaki Kubo; Norihiro Shimokawa; Mina Sato-Kasai; Kohei Hayakawa; Nobuki Kuwano; Wakako Umene-Nakano; Masaru Tateno; Daiki Setoyama; Dongchon Kang; Motoki Watabe; Shinji Sakamoto; Alan R Teo; Shigenobu Kanba
Journal:  Psychiatry Clin Neurosci       Date:  2019-04-29       Impact factor: 5.188

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.